Trial intelligence / Profile preview

Phase II oxaliplatin + capecitabine in advanced esophageal cancer

NL-OMON20867Phase 2Active, not recruiting

Sponsor

N/A

Start

Apr 2003

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1